Decisions analysed

Find a decision of the Unified Patent Court, consult its official source and identify the firm’s case notes to understand its practical implications.

Find a decision in three steps

  1. 1. SearchEnter a party name, case number or keyword.
  2. 2. RefineUse the filters to refine your search, then select Filter.
  3. 3. ReadOpen a title. The “Decision with commentary” badge identifies a case note by the firm.
Scope, method and reading key

UPC decisions and orders since 1 June 2023. “Decision with commentary” means the entry contains an analysis by Dhenne Avocats. “Summary available” identifies a summary; “Reference” identifies a record without a detailed case note. Open the entry for the source and, where available, the facts, reasoning and practical implications. The official decision is authoritative.

127 decisions match these criteria.

Zentiva France v Sanofi Mature IP (CFI, 24 January 2025)

24 January 2025 CFI / Munich (DE) Local Division / Counterclaim for revocation Decision with commentary

In a procedural order of 24 January 2025, the Munich Local Division set the timetable for the proceedings on EP 2 493 466 between the Sanofi companies and Accord Healthcare, STADA, Dr Reddy’s and Zentiva (UPC_CFI_145, 146, 147, 148, 374, 463, 496…

Read the analysis

Sanofi Winthrop Industrie v Accord Healthcare (CFI, 22 January 2025)

22 January 2025 CFI / Munich (DE) Local Division / Generic Order Decision with commentary

By a common order of 22 January 2025, issued after the preliminary interim conference in Sanofi's four joined infringement actions against Accord, Stada, Reddy and Zentiva (UPC_CFI_145/2024 to UPC_CFI_148/2024, EP 2 493 466, cabazitaxel), the judge-rapporteur of the Munich Local Division (Judge…

Read the analysis

EOFLOW v Insulet (CoA, 10 January 2025)

10 January 2025 CoA / Luxembourg (LU) / Appeal RoP220.2 Decision with commentary

By order of 9 January 2025 (UPC_CoA_584/2024), the Court of Appeal disposed of EOFlow’s appeal as devoid of purpose. The appeal challenged the Milan Central Division’s order of 24 September 2024 refusing to join Insulet’s application for provisional measures against EOFlow (EP…

Read the analysis

Insulet v A. Menarini Diagnostics (CoA, APL_64383/2024, 9 January 2025)

9 January 2025 CoA / Luxembourg (LU) / Application RoP262A Decision with commentary

By order of 9 January 2025 (UPC_CoA_769/2024), the judge-rapporteur of the Court of Appeal held that A. Menarini Diagnostics’ confidentiality request in Insulet’s appeal against the Milan Local Division’s refusal of provisional measures (EP 4 201 327) was superfluous.

Read the analysis

Sanofi Mature IP v Accord Healthcare (CFI, 7 January 2025)

7 January 2025 CFI / Munich (DE) Local Division / Application Rop305 Decision with commentary

By an order of 7 January 2025, made in the parallel infringement actions on EP 2 493 466 (UPC_CFI_145/2024 to UPC_CFI_148/2024, against Accord Healthcare, STADA, Reddy and Zentiva), Judge Zigann, judge-rapporteur at the Munich Local Division, substituted Sanofi Winthrop Industrie for Sanofi-Aventis…

Read the analysis

Insulet v Eoflow (CFI, 30 December 2024)

30 December 2024 CFI / Milan (IT) Local Division / Generic application Decision with commentary

By an order of 30 December 2024 (UPC_CFI_400/2024, ORD_60558/2024), the judge-rapporteur of the Milan Local Division (Judge Zana) dismissed Insulet's application for a costs decision against Eoflow, whose application to intervene in support of A.

Read the analysis

Insulet v A. Menarini Diagnostics (CFI, 23 December 2024)

23 December 2024 CFI / Milan (IT) Central Division- Section / Generic application Decision with commentary

By an order of 23 December 2024 (UPC_CFI_380/2024, ORD_59988/2024), the judge-rapporteur of the Milan Central Division (Judge Postiglione) ordered A. Menarini Diagnostics to pay Insulet EUR 1,764 for the costs of opposing its application to intervene, refused on 1 October 2024, in…

Read the analysis

Alexion Pharmaceuticals v Samsung Bioepis NL (CoA, 20 December 2024)

20 December 2024 CoA / Luxembourg (LU) / Appeal RoP220.1 Decision with commentary

In an order of 20 December 2024 (UPC_CoA_402/2024), the Court of Appeal dismissed Alexion’s appeal against the Hamburg Local Division’s refusal to grant provisional measures against Samsung Bioepis’s marketing of Epysqli®, a biosimilar of Soliris® (eculizumab), under EP 3 167 888.

Read the analysis

Insulet v A. Menarini Diagnostics (CFI, 22 November 2024)

22 November 2024 CFI / Milan (IT) Local Division / Application for provisional measures Decision with commentary

By order of 22 November 2024 (UPC_CFI_400/2024, App_40442/2024), made after the hearing of 15 October 2024, the Milan Local Division (panel presided over by P. Perrotti) dismissed Insulet Corporation's application for provisional measures against A.

Read the analysis

Insulet v EOFLOW (CFI, 22 November 2024)

22 November 2024 CFI / Milan (IT) Central Division- Section / Application for provisional measures Decision with commentary

By order of 22 November 2024 (UPC_CFI_380/2024), made after the hearing of 16 October 2024, the Milan Central Division (panel presided over by A. Postiglione) dismissed Insulet Corporation's application for provisional measures against EOFLOW Co., Ltd.

Read the analysis

EOFLOW v Insulet (CoA, 9 October 2024)

9 October 2024 CoA / Luxembourg (LU) / Generic Order Decision with commentary

In an order of 9 October 2024 (UPC_CoA_584/2024), the Court of Appeal refused EOFlow’s request to expedite its appeal against the order of 24 September 2024 of the Milan Central Division, which had declined to join Insulet’s application for provisional measures against…

Read the analysis

EOFLOW v Insulet (CFI, 1 October 2024)

1 October 2024 CFI / Milan (IT) Central Division- Section / Generic Order Decision with commentary

By order of 1 October 2024 (UPC_CFI_380/2024, ORD_52068/2024), the Milan Central Division (A. Postiglione, presiding and judge-rapporteur, A.-L.

Read the analysis

Insulet v A. Menarini Diagnostics (CFI, 1 October 2024)

1 October 2024 CFI / Milan (IT) Local Division / Application for provisional measures Decision with commentary

By order of 1 October 2024 (UPC_CFI_400/2024), the Milan Local Division dismissed the application of EOFlow, the manufacturer of the EOPatch insulin patch pump, to intervene in support of its exclusive distributor A.

Read the analysis

EOFLOW v INSULET (CFI, 24 September 2024)

24 September 2024 CFI / Milan (IT) Central Division- Section / Application Rop 333 Decision with commentary

By an order of 24 September 2024 (UPC_CFI_380/2024), the panel of the Milan Central Division (A. Postiglione, presiding judge and judge-rapporteur, A.-L.

Read the analysis

Alexion Pharmaceuticals v Samsung Bioepis NL (CoA, 30 July 2024)

30 July 2024 CoA / Luxembourg (LU) / Generic application Decision with commentary

By order of 30 July 2024 (UPC_CoA_402/2024, APL_40470/2024), the Court of Appeal rejected Alexion Pharmaceuticals' request to expedite its appeal against the Hamburg Local Division's dismissal of its application for provisional measures against Samsung Bioepis NL on EP 3 167 888.

Read the analysis